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regression) almost exclusively due to increased risk of periprocedural myocardial
infarction (MI) (1.6% vs. 0.2%; p=0.050), while the rates of cardiac death, spontaneous
MI, and target lesion revascluarization did not differ significantly between the two
groups.
Conclusion: The adjunctive use of IVUS during PCI in the EXCELLENT trial was
associated with more stents implanted, longer stenting, and bigger stenting. There were
no significant advantages of IVUS guidance regarding clinical outcome, but rather a
significant increase in periprocedural enzyme elevation, reflecting the more aggressive
procedures performed with IVUS guidance.
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Background: The impact of tissue prolapse (TP) on clinical outcomes after stent
implantation is still not well known. We used intravascular ultrasound (IVUS) to
evaluate the association of TP with short- and long-term clinical outcomes after stent
implantation in 418 acute myocardial infarction (AMI) patients (155 ST segment
elevation and 263 non-ST segment elevation MI).
Methods: TP was defined as tissue extrusion through the stent strut at post-stenting.
We evaluated the incidences of stent thrombosis, no-reflow, and long-term clinical
outcomes.
Results: After stenting, TP was detected in 34% without difference according to the
stent types. Acute and subacute stent thromboses occurred more frequently in patients
with TP compared with those without TP (3.5% vs. 0.7%, p=0.035, and 4.2% vs. 0.7%,
p=0.013, respectively). However, no significant difference was observed in the
incidence of late stent thrombosis between both groups. No-reflow was developed
more frequently in patients with TP compared with those without TP (25.4% vs. 9.8%,
p<0.001). Creatine kinase-MB and cardiac specific troponin-I were elevated more
significantly after stenting in patients with TP compared with those without TP
(+9.0±25.2 U/l vs. -4.2±41.6 U/l, p=0.001 and +10.0±43.5 ng/ml vs. -1.2±35.6 ng/ml,
p=0.005, respectively). There were no significant differences in the incidences of
cardiac death, MI, and target vessel revascularization at 1-year. Multivariate analysis
showed that TP was the independent predictor of composite of acute and subacute stent
thrombosis (OR=4.211; 95% CI 1.198-14.805, p=0.025) and composite of acute stent
thrombosis and no-reflow (OR=2.551; 95% CI 1.315-4.952, p=0.006).
Conclusion: TP was associated with short-term complications (acute and subacute
thrombosis and no-reflow phenomenon), however it was not affect long-term clinical
outcomes after stent implantation in patients with AMI.
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Background: Fully bioresorbable everolimus-eluting vascular scaffolds (ABSORB,
Abbott Vascular, Santa Clara, USA) are a novel approach to treat coronary stenosis.
However the outcome of jailed side branch with ABSORB has not been investigated
yet. The purpose of this study is to assess the fate of struts covering the ostium of side-
branches at 6, 12 and 24 months after implantation of the BVS with three-dimensional
(3-D) optical coherence tomography (OCT) reconstruction.
Methods: The ABSORB Cohort B trial is a single-arm trial to assess the safety and
performance of the BVS. The first 45 patients (Group 1) underwent invasive imaging
at 6 months and at 2 years, while the remained 56 patients (Group 2) underwent
imaging follow-up at 1 and will repeat it at 3 years. FD-OCT imaging (C7XR system)
are obtained at a pullback speed of 20 mm/s.
Results: Paired 3D images at baseline and 6 months were available in 16 side branches,
while paired analysis at baseline and 12-month follow-up were available in 17 side
branches. At 6 months, the average ostium area free from jailing struts did not change
from baselines (BL: 1.73 ± 1.35 mm2, FU: 1.64 ± 1.21 mm2, p=0.7), and the number
of compartments was similar between baseline and 6 months following implantation
(BL: 2.07±1.1, 6M: 1.93±1.0, p=0.16). At 12 months, 3D OCT showed that
membranous tissue covers some struts, which was translated into a significant decrease
in the number of compartments from 2.1 ± 0.8 at baseline to 1.4 ± 0.85 at 12 months
(p=0.001). This was accompanied by a decrease in the strut-free ostial area (BL: 1.89
± 1.35 vs. 12M: 0.76 ± 1.98 mm2) without clinical implication.
Conclusion: The 3-D analysis showed that the ostial area free of struts remained
unchanged at 6 months compared to baseline, while it was reduced at 12 months due
to growing tissue covering the struts. The results of 2-year imaging will be presented
at the time of meeting.
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Background: Pathologic studies suggest that calcified coronary nodules account for
2-7% of thrombotic events. The frequency, distribution, predictors, and outcomes of
calcified nodules detected in vivo have never been described.
Methods: Following successful stenting in 697 patients with acute coronary syndromes
(ACS), three-vessel grayscale and virtual histology (VH) intravascular ultrasound
(IVUS) was performed. Based on histologic validation, an independent core lab
identified calcified nodule as irregular and convex plaque shape. Patients were followed
for three years.
Results: Overall, 314 calcified nodules were detected in 250 of 1573 analyzable
arteries (185 of 623 patients). Thus, the prevalence of calcified nodules was 17% per
artery and 30% per patient. The location of the calcified nodules were <40mm of the
ostium of the coronary artery in 85% of LAD and 86% of LCX while calcified nodules
within the RCA were evenly and more distally distributed. Patients with calcified
nodules were significantly older, had more plaque volume (IVUS), and more thick-
capped fibroatheroma (VH-IVUS), but fewer non-culprit lesion major adverse events
on follow-up.
Table. Clinical Characteristics, imaging parameters and clinical event rates
comparing patients with vs without calcified nodules
DC = dense calcium; NC = necrotic core
Conclusion: Calcified nodules in untreated non-culprit coronary segments in patients
with ACS are more prevalent than previously recognized; their distribution mirrors the
origin of most thrombotic events. However, they are unlikely to cause events during
3-year follow-up.
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Background: To analyze our experience with intraoperative shuntography for
immediate evaluation of coronary shunts condition in patients after CABG.
Methods: The study comprised 1084 patients who received 2707 coronary shunts
during the period from February 2009 through April 2011. The patients’ age varied
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